RET

RET(REarranged during Transfection)是一种跨膜受体酪氨酸激酶,由可溶性胶质细胞系衍生的神经营养因子 (GDNF) 家族配体 (GFL) 和糖基磷脂酰肌醇锚定辅助受体 GDNF 家族受体 α (GFRalpha) 组成的复合物激活。

RET 信号传导对于肠神经系统的发育至关重要。RET 调节交感神经、副交感神经、运动和感觉神经元的发育,并且对于多巴胺能神经元的出生后维持必不可少。RET 还在多种人类癌症中发挥驱动致癌基因的作用。在乳头状甲状腺癌、肺癌、结直肠癌、胰腺癌和乳腺癌中均检测到了 RET 与几种伴侣基因的融合,而 RET 的酪氨酸激酶抑制剂 (TKI)(尤其是 RET 特异性抑制剂)对此类癌症显示出良好的治疗效果。

RET (REarranged during Transfection) is a transmembrane receptor tyrosine kinase that is activated by a complex consisting of a soluble glial cell line-derived neurotrophic factor (GDNF) family ligand (GFL) and a glycosyl phosphatidylinositol-anchored co-receptor, GDNF family receptors alpha (GFRalpha).

RET signalling is crucial for the development of the enteric nervous system. RET regulates the development of sympathetic, parasympathetic, motor, and sensory neurons, and is necessary for the postnatal maintenance of dopaminergic neurons. RET also plays a role as a driver oncogene in a variety of human cancers. Fusion of RET with several partner genes has been detected in papillary thyroid, lung, colorectal, pancreatic, and breast cancers, and tyrosine kinase inhibitors (TKIs) for RET (particularly RET-specific inhibitors) show promising effects against such cancers.

共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
BT44

BT44 是一种选择性 RET 活化剂,可穿透血脑屏障,可用于神经退行性疾病及糖尿病的研究。

924759-42-2
Activator
98.87%
BT44
Sominone

Sominone 是 Withanoside IV (MS-N56462) 的活性代谢产物,可通过激活 RET 通路增强神经元形态可塑性,也可诱导轴突/树突再生及突触重建,进而改善空间记忆,因此可用于阿尔兹海默症等神经退行性疾病的研究。

98569-64-3
Activator
99.96%
Sominone

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础